serw-MX  [xml]  
 
    
 DeCS Categories

A12 Fluids and Secretions .
A12.207 Body Fluids .
A12.207.152 Blood .
A15 Hemic and Immune Systems .
A15.145 Blood .
C10 Nervous System Diseases .
C10.228 Central Nervous System Diseases .
C10.228.758 Ocular Motility Disorders .
C10.292 Cranial Nerve Diseases .
C10.292.562 Ocular Motility Disorders .
C11 Eye Diseases .
C11.590 Ocular Motility Disorders .
C15 Hemic and Lymphatic Diseases .
C15.378 Hematologic Diseases .
C15.378.553 Leukocyte Disorders .
C15.378.553.475 Leukocytosis .
C15.378.553.475.604 Lymphocytosis .
C18 Nutritional and Metabolic Diseases .
C18.452 Metabolic Diseases .
C18.452.584 Lipid Metabolism Disorders .
C18.452.584.500 Dyslipidemias .
C18.452.584.500.500 Hyperlipidemias .
C18.452.584.500.500.851 Hypertriglyceridemia .
D10 Lipids .
D27 Chemical Actions and Uses .
D27.505 Pharmacologic Actions .
D27.505.519 Molecular Mechanisms of Pharmacological Action .
D27.505.519.186 Antimetabolites .
D27.505.519.186.071 Hypolipidemic Agents .
D27.505.954 Therapeutic Uses .
D27.505.954.557 Lipid Regulating Agents .
D27.505.954.557.500 Hypolipidemic Agents .
G02 Chemical Phenomena .
G02.111 Biochemical Phenomena .
G02.111.534 Lipolysis .
G03 Metabolism .
G03.458 Lipid Metabolism .
G03.458.500 Lipolysis .
 
 Terms
 Synonyms & Historicals		Documents
LILACS e MDL		 
Hyperlipidemias .
Hyperlipidemia .
Lipemia .
Lipidemia .
Hyperlipemias .
Lipemias .
Lipidemias .
Hyperlipemia .
Conditions with excess LIPIDS in the blood. .
1.00
70124372
 
Lipids .
Lipids and Antilipemic Agents .
A generic term for fats and lipoids, the alcohol-ether-soluble constituents of protoplasm, which are insoluble in water. They comprise the fats, fatty oils, essential oils, waxes, phospholipids, glycolipids, sulfolipids, aminolipids, chromolipids (lipochromes), and fatty acids. (Grant & Hackh's Chemical Dictionary, 5th ed) .
0.42
142894231
 
Lymphocytosis .
Lymphocytoses .
Excess of normal lymphocytes in the blood or in any effusion. .
0.39
502448
 
Lipolysis .
Lipolyses .
The metabolic process of breaking down LIPIDS to release FREE FATTY ACIDS, the major oxidative fuel for the body. Lipolysis may involve dietary lipids in the DIGESTIVE TRACT, circulating lipids in the BLOOD, and stored lipids in the ADIPOSE TISSUE or the LIVER. A number of enzymes are involved in such lipid hydrolysis, such as LIPASE and LIPOPROTEIN LIPASE from various tissues. .
0.38
616639
 
Hypolipidemic Agents .
Antihyperlipemics .
Antihyperlipidemics .
Antilipemic Drugs .
Antilipemics .
Hypolipidemic Drugs .
Agents, Antilipemic .
Agents, Hypolipidemic .
Drugs, Antilipemic .
Drugs, Hypolipidemic .
Antilipemic Agents .
ANTILIPIDERMIC AGENTS .
Substances that lower the levels of certain LIPIDS in the BLOOD. They are used to treat HYPERLIPIDEMIAS. .
0.37
12913859
 
/blood .
Used for the presence or analysis of substances in the blood; also for examination of, or changes in, the blood in disease states. It excludes serodiagnosis, for which the subheading "diagnosis" is used, and serology, for which "immunology" is used. .
0.37
 
Blood .
The body fluid that circulates in the vascular system (BLOOD VESSELS). Whole blood includes PLASMA and BLOOD CELLS. .
0.37
65133499
 
Ocular Motility Disorders .
Brown's Tendon Sheath Syndrome .
Convergence Excess .
Cyclophoria .
Deficiency, Smooth Pursuit .
Eye Motility Disorders .
Parinaud's Syndrome .
Paroxysmal Ocular Dyskinesia .
Pseudoophthalmoplegia .
Spasm of Conjugate Gaze .
Syndrome, Brown's Tendon Sheath .
Tendon Sheath Syndrome of Brown .
Conjugate Gaze Spasm .
Conjugate Gaze Spasms .
Convergence Excesses .
Convergence Insufficiencies .
Cyclophorias .
Deficiencies, Smooth Pursuit .
Deviation, Skew .
Deviations, Skew .
Dyskinesia, Paroxysmal Ocular .
Dyskinesias, Paroxysmal Ocular .
Excess, Convergence .
Eye Motility Disorder .
Eye Movement Disorder .
Gaze Spasms, Conjugate .
Insufficiencies, Convergence .
Insufficiency, Convergence .
Internuclear Ophthalmoplegias .
Ocular Dyskinesia, Paroxysmal .
Ocular Dyskinesias, Paroxysmal .
Ocular Motility Disorder .
Ophthalmoplegia, Internuclear .
Ophthalmoplegias, Internuclear .
Parinauds Syndrome .
Paroxysmal Ocular Dyskinesias .
Pseudoophthalmoplegias .
Pursuit Deficiencies, Smooth .
Pursuit Deficiency, Smooth .
Skew Deviations .
Smooth Pursuit Deficiencies .
Syndrome, Parinaud .
Syndrome, Parinaud's .
Ocular Torticollis .
Eye Movement Disorders .
Opsoclonus .
Brown Tendon Sheath Syndrome .
Convergence Insufficiency .
Internuclear Ophthalmoplegia .
Parinaud Syndrome .
Skew Deviation .
Smooth Pursuit Deficiency .
EYE MOTILITY DISORDERS .
Disorders that feature impairment of eye movements as a primary manifestation of disease. These conditions may be divided into infranuclear, nuclear, and supranuclear disorders. Diseases of the eye muscles or oculomotor cranial nerves (III, IV, and VI) are considered infranuclear. Nuclear disorders are caused by disease of the oculomotor, trochlear, or abducens nuclei in the BRAIN STEM. Supranuclear disorders are produced by dysfunction of higher order sensory and motor systems that control eye movements, including neural networks in the CEREBRAL CORTEX; BASAL GANGLIA; CEREBELLUM; and BRAIN STEM. Ocular torticollis refers to a head tilt that is caused by an ocular misalignment. Opsoclonus refers to rapid, conjugate oscillations of the eyes in multiple directions, which may occur as a parainfectious or paraneoplastic condition (e.g., OPSOCLONUS-MYOCLONUS SYNDROME). (Adams et al., Principles of Neurology, 6th ed, p240) .
0.36
873205
 
Hypertriglyceridemia .
Hypertriglyceridemias .
A condition of elevated levels of TRIGLYCERIDES in the blood. .
0.36
2045243